tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
VRNA is currently covered by 7 analysts with an average price target of $50.17. This is a potential upside of $11.36 (29.27%) from yesterday's end of day stock price of $38.81.
Verona Pharma PLC ADR's activity chart (see below) currently has 26 price targets and 58 ratings on display. The stock rating distribution of VRNA is 97.3% BUY and 2.7% SELL.
Analysts average stock forecasts to be materialized ratio is 75.47% with an average time for these price targets to be met of 499.38 days.
Highest price target for VRNA is $44, Lowest price target is $33, average price target is $50.17.
Most recent stock forecast was given by EDWARD NASH from CANACCORD on 05-Nov-2024. First documented stock forecast 22-May-2017.
Currently out of the existing stock ratings of VRNA, 36 are a BUY (97.3%), 1 are a SELL (2.7%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$44
$5.19 (13.37%)
$37
18 days ago
(05-Nov-2024)
11/12 (91.67%)
$4.93 (12.62%)
498
Buy
$42
$3.19 (8.22%)
$36
18 days ago
(05-Nov-2024)
21/22 (95.45%)
$2.93 (7.50%)
341
Buy
$33
$-5.81 (-14.97%)
$30
8 months 22 days ago
(01-Mar-2024)
5/6 (83.33%)
$14.81 (81.42%)
608
Buy
$32
$15.27 (91.27%)
$32
1 years 4 months 28 days ago
(27-Jun-2023)
2/6 (33.33%)
$11.78 (58.26%)
206
Buy
$38
$-0.81 (-2.09%)
$17
1 years 6 months 1 days ago
(22-May-2023)
2/2 (100%)
$16.67 (78.15%)
690
What is VRNA (Verona Pharma PLC ADR) average time for price targets to be met?
Which analyst has the current highest performing score on VRNA (Verona Pharma PLC ADR) with a proven track record?
Which analyst has the current lower performing score on VRNA (Verona Pharma PLC ADR) with a proven track record?
Which analyst has the most public recommendations on VRNA (Verona Pharma PLC ADR)?
Which analyst is the currently most bullish on VRNA (Verona Pharma PLC ADR)?
Which analyst is the currently most reserved on VRNA (Verona Pharma PLC ADR)?
